MSD
A Principal Scientist at Merck's South San Francisco Research & Development division leads Pharmacokinetics, Dynamics, Metabolism, and Bioanalytics (PDMB) projects for biologics and novel drug modalities. The role involves designing translational studies, authoring regulatory documents, and providing strategic DMPK guidance to optimize therapeutic proteins and support drug discovery. This position requires collaborating across multidisciplinary teams to drive program progression and influence drug design decisions.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
22% above the average for this role
MSD ends takeover talks with Revolution Medicines
1 month ago
Associate Director, Drug Metabolism and Pharmacokinetics
Insmed Incorporated
Principal Scientist (Director-Level Equivalent)
Merck & Co., Inc.
Director, Translational Science/Pharmacokinetics
Tarsus Pharmaceuticals
Director, Pharmacokinetics
Merck & Co., Inc.
Director, Translational Science/Pharmacokinetics
Tarsus Pharmaceuticals
Contractor, Drug Metabolism and Pharmacokinetics (DMPK)
PTC Therapeutics